| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PFE | Common Stock | Options Exercise | $266,620 | +9,752 | +103% | $27.34 | 19,228 | 23 Feb 2024 | Direct | F1 |
| transaction | PFE | Common Stock | Tax liability | $12,520 | -451 | -2.3% | $27.76 | 18,777 | 23 Feb 2024 | Direct | F2 |
| transaction | PFE | Common Stock | Tax liability | $21,486 | -774 | -4.1% | $27.76 | 18,003 | 23 Feb 2024 | Direct | F3 |
| transaction | PFE | Common Stock | Tax liability | $215,703 | -7,881 | -44% | $27.37 | 10,122 | 23 Feb 2024 | Direct | F4, F5 |
| transaction | PFE | Common Stock | Tax liability | $9,827 | -354 | -3.5% | $27.76 | 9,768 | 24 Feb 2024 | Direct | F2, F6 |
| transaction | PFE | Common Stock | Tax liability | $38,475 | -1,386 | -14% | $27.76 | 8,382 | 25 Feb 2024 | Direct | F2, F6 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PFE | Stock Appreciation Rights | Options Exercise | $0 | -9,752 | -100% | $0.000000* | 0 | 23 Feb 2024 | Common Stock | 9,752 | $27.34 | Direct |
| Id | Content |
|---|---|
| F1 | The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). |
| F2 | The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon). |
| F3 | The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. |
| F4 | The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). |
| F5 | Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. |
| F6 | Price is the closing price of Pfizer common stock on February 23, 2024. |